References
- Ahmad, A., Aboukameel, A., Kong, D., Wang, Z., Sethi, S., Chen, W., Sarkar, F. H. and Raz, A. 2011. Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells. Cancer Res. 71, 3400-3409. https://doi.org/10.1158/0008-5472.CAN-10-0965
- Bodempudi, V., Hergert, P., Smith, K., Xia, H., Herrera, J., Peterson, M., Khalil, W., Kahm, J., Bitterman, P. B. and Henke, C. A. 2014. miR-210 promotes IPF fibroblast proliferation in response to hypoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 307, L283-294. https://doi.org/10.1152/ajplung.00069.2014
- Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. and Cohen, S. M. 2003. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36. https://doi.org/10.1016/S0092-8674(03)00231-9
- Chan, S. Y., Zhang, Y. Y., Hemann, C., Mahoney, C. E., Zweier, J. L. and Loscalzo, J. 2009. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell. Metab. 10, 273-284. https://doi.org/10.1016/j.cmet.2009.08.015
- Cong, N., Du, P., Zhang, A., Shen, F., Su, J., Pu, P., Wang, T., Zjang, J., Kang, C. and Zhang, Q. 2013. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Oncol. Rep. 29, 1579-1587. https://doi.org/10.3892/or.2013.2267
- Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C. and Martelli, F. 2008. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 283, 15878-15883. https://doi.org/10.1074/jbc.M800731200
- Firth, S. M and Baxter, R. C. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23, 824-854. https://doi.org/10.1210/er.2001-0033
- Gao, S. L., Wang, L. Z., Liu, H. Y., Liu, D. L., Xie, L. M. and Zhang, Z. W. 2014. miR-200a inhibits tumor proliferation by targeting AP-2gamma in neuroblastoma cells. Asian. Pac. J. Cancer Prev. 15, 4671-4676. https://doi.org/10.7314/APJCP.2014.15.11.4671
- Giannakakis, A., Sandaltzopoulos, R., Greshock, J., Liang, S., Huang, J., Hasegawa, K, Li, C., O'Brien-Jenkins, A., Katsaros, D., Weber, B. L., Simon, C., Coukos, G. and Zhang, L. 2008. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7, 255-264. https://doi.org/10.4161/cbt.7.2.5297
- Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y. Y., Lindeman, G. J., Shannon, M. F., Drew, P. A., Khew-Goodall, Y. and Goodall, G. J. 2011. An autocrine TGF-beta/ ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol. Biol. Cell 22, 1686-1698. https://doi.org/10.1091/mbc.E11-02-0103
- Hua, Z., Lv, Q., Ye, W., Wong, C. K., Cai, G., Gu, D., Ji, Y., Zhao, C., Wang, J., Yang, B. B. and Zhang, Y. 2006. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1, e116. https://doi.org/10.1371/journal.pone.0000116
- Huang, X., Le, Q. T. and Giaccia, A. J. 2010. MiR-210-micromanager of the hypoxia pathway. Trends Mol. Med. 16, 230-237. https://doi.org/10.1016/j.molmed.2010.03.004
- Johnston, R. J. and Hobert, O. 2003. microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans. Nature 426, 845-849. https://doi.org/10.1038/nature02255
- Kalluri, H. S. and Dempsey, R. J. 2011. IGFBP-3 inhibits the proliferation of neural progenitor cells. Neurochem. Res. 6, 406-411.
- Kamanga-Sollo, E., Pampusch, M. S., Whitem M. E. and Dayton, W. R. 2003. Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-beta- and GDF-8 (myostatin)- induced suppression of proliferation in porcine embryonic myogenic cell cultures. J. Cell. Physiol. 197, 225-231. https://doi.org/10.1002/jcp.10362
- Kim, J. H., Park, S. G., Song, S. Y., Kim, J. K. and Sung, J. H. 2013. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell. Death. Dis. 4, e588. https://doi.org/10.1038/cddis.2013.117
- Kim, Y. J., Bae, S. W., Yu, S. S., Bae, Y. C. and Jung, J. S. 2009. miR-196a regulates proliferation and osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue. J. Bone. Miner. Res. 24, 816-825. https://doi.org/10.1359/jbmr.081230
- Kim, Y. J., Hwang, S. J., Bae, Y. C. and Jung, J. S. 2009. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells 27, 3093-3102.
- Korpal, M., Lee, E. S., Hu, G. and Kang, Y. 2008. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J. Biol. Chem. 283, 14910-14914. https://doi.org/10.1074/jbc.C800074200
- Levi, B., Wan, D. C., Glotzbach, J. P., Hyun, J., Januszyk, M., Montoro, D., Sorkin, M., James, A. W., Nelson, E. R., Li, S., Quarto, N., Lee, M., Gurtner, G. C. and Longaker, M. T. 2011. CD105 protein depletion enhances human adipose- derived stromal cell osteogenesis through reduction of transforming growth factor beta1 (TGF-beta1) signaling. J. Biol. Chem. 286, 39497-39509. https://doi.org/10.1074/jbc.M111.256529
- Li, H., Tang, J., Lei, H., Cai, P., Zhu, H., Li, B., Xu, X., Xia, Y. and Tang, W. 2014. Decreased MiR-200a/141 suppress cell migration and proliferation bytargeting PTEN in Hirschsprung's disease. Cell. Physiol. Biochem. 34, 543-553. https://doi.org/10.1159/000363021
- Li, J., Jin, D., Fu, S., Mei, G., Zhou, J., Lei, L., Yu, B. and Wang, G. 2013. Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor. Biochem. Biophys. Res. Commun. 436, 632-637. https://doi.org/10.1016/j.bbrc.2013.04.111
- Liang, W. C., Wang, Y., Wan, D. C., Yeung, V. S. and Waye, M. M. 2013. Characterization of miR-210 in 3T3-L1 adipogenesis. J. Cell. Biochem. 114, 2699-2707. https://doi.org/10.1002/jcb.24617
- Liu, Y., Liu, Q., Jia, W., Chen, J., Wang, J., Ye, D., Guo, X., Chen, W., Li, G., Wang, G., Deng, A. and Kang, J. 2013. MicroRNA-200a regulates Grb2 and suppresses differentiation of mouse embryonic stem cells into endoderm and mesoderm. PLoS One 8, e68990. https://doi.org/10.1371/journal.pone.0068990
- Lu, D. F., Yao, Y., Su, Z. Z., Zeng, Z. H., Xing, X. W., He, Z. Y. and Zhang, C. 2014. Downregulation of HDAC1 is involved in the cardiomyocyte differentiation from mesenchymal stem cells in a myocardial microenvironment. PLoS One 9, e93222. https://doi.org/10.1371/journal.pone.0093222
- Mizuno, Y., Tokuzawa, Y., Ninomiya, Y., Yagi, K., Yatsuka- Kanesaki, Y., Suda, T., Fukuda, T., Katagiri, T., Kondoh, Y., Amemiya, T., Tashiro, H. and Okazaki, Y. 2009. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS. Lett. 583, 2263-2268. https://doi.org/10.1016/j.febslet.2009.06.006
- Nagaoka, K., Zhang, H., Watanabe, G. and Taya, K. 2013. Epithelial cell differentiation regulated by MicroRNA-200a in mammary glands. PLoS One 8, e65127. https://doi.org/10.1371/journal.pone.0065127
- Ochiai, H., Okada, S., Saito, A., Hoshi, K., Yamashita, H., Takato, T. and Azuma, T. 2012. Inhibition of insulin-like growth factor-1 (IGF-1) expression by prolonged transforming growth factor-beta1 (TGF-beta1) administration suppresses osteoblast differentiation. J. Biol. Chem. 287, 22654-22661. https://doi.org/10.1074/jbc.M111.279091
- Pampusch, M. S., Kamanga-Sollo, E., Hathaway, M. R., White, M. E. and Dayton, W. R. 2011. Low-density lipoprotein- related receptor protein 1 (LRP-1) is not required for insulin-like growth factor binding protein 3 (IGFBP-3) to suppress L6 myogenic cell proliferation. Domest. Anim. Endocrinol. 40, 197-204. https://doi.org/10.1016/j.domaniend.2011.01.001
- Park, S. M., Gaur, A. B., Lengyel, E. and Peter, M. E. 2008. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes. Dev. 22, 894-907. https://doi.org/10.1101/gad.1640608
- Peng, C., Li, N., Ng, Y. K., Zhang, J., Meier, F., Theis, F. J., Merkenschlager, M., Chen, W., Wurst, W. and Prakash, N. 2012. A unilateral negative feedback loop between miR- 200 microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentiation. J. Neurosci. 32, 13292-13308. https://doi.org/10.1523/JNEUROSCI.2124-12.2012
- Puisségur, M. P., Mazure, N. M., Bertero, T., Pradelli, L., Grosso, S., Robbe-Sermesant, K., Maurin, T., Lebrigand, K., Cardinaud, B., Hofman, V., Fourre, S., Magnone, V., Ricci, J. E., Pouysségur, J., Gounon, P., Hofman, P., Barbry, P. and Mari, B. 2011. miR-210 is overexpressed in late stages of lung cancerand mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ. 18, 465-478. https://doi.org/10.1038/cdd.2010.119
- Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J. and Ylä-Herttuala, S. 2008. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS. Lett. 582, 2397-2401. https://doi.org/10.1016/j.febslet.2008.05.048
- Raucci, A., Bellosta, P., Grassi, R., Basilico, C. and Mansukhani, A. 2008. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J. Cell. Physiol. 215, 442-451. https://doi.org/10.1002/jcp.21323
- Rhodes, S. D., Wu, X., He, Y., Chen, S., Yang, H., Staser, K. W., Wang, J., Zhang, P., Jiang, C., Yokota, H., Dong, R., Peng, X., Yang, X., Murthy, S., Azhar, M., Mohammad, K. S., Xu, M., Guise, T. A. and Yang, F. C. 2013.Hyperactive transforming growth factor-beta1 signaling potentiates skeletal defects in a neurofibromatosis type 1 mouse model. J. Bone Miner. Res. 28, 2476-2489. https://doi.org/10.1002/jbmr.1992
- Shin, K. K., Kim, Y. S., Kim, J. Y., Bae, Y. C. and Jung, J. S. 2014. miR-137 controls proliferation and differentiation of human adipose tissue stromal cells. Cell. Physiol. Biochem. 33, 758-768. https://doi.org/10.1159/000358650
- Tarantino, C., Paolella, G., Cozzuto, L., Minopoli, G., Pastore, L., Parisi, S. and Russo, T. 2010. miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. Faseb. J. 24, 3255-3263. https://doi.org/10.1096/fj.09-152207
- Tsuchiya, S., Fujiwara, T., Sato, F., Shimada, Y., Tanaka, E., Sakai, Y., Shimizu, K. and Tsujimoto, G. 2011. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 286, 420-428. https://doi.org/10.1074/jbc.M110.170852
- Uhlmann, S., Zhang, J. D., Schwager, A., Mannsperger, H., Riazalhosseini, Y.,Burmester, S., Ward, A., Korf, U., Wiemann, S. and Sahin, O. 2010. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and GF-driven invasion than miR-200a/141 in breast cancer. Oncogene 29, 4297-4306. https://doi.org/10.1038/onc.2010.201
- Verstappen, G., van Grunsven, L. A., Michiels, C., Van de Putte, T., Souopgui J.,Van Damme, J., Bellefroid, E., Vandekerckhove, J. and Huylebroeck, D. 2008. Atypical Mowat-Wilson patient confirms the importance of the novel association between ZFHX1B/SIP1 and NuRD corepressor complex. Hum. Mol. Genet. 17, 1175-1183. https://doi.org/10.1093/hmg/ddn007
- Wang, Z., Yin, B., Wang, B., Ma, Z., Liu, W. and Lv, G. 2014. MicroRNA-210 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3. Oncol. Res. 21, 145-154. https://doi.org/10.3727/096504013X13841340689573
- Xia, H., Ng, S. S., Jiang, S., Cheung, W. K., Sze, J., Bian, X. W., Kung, H. F. and Lin, M. C. 2010. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion. Biochem. Biophys. Res. Commun. 391, 535-541. https://doi.org/10.1016/j.bbrc.2009.11.093
- Xu, P., Vernooy, S. Y., Guo, M. and Hay, B. A. 2003. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr. Biol. 13, 790-795. https://doi.org/10.1016/S0960-9822(03)00250-1
- Yang, W., Sun, T., Cao, J., Liu, F., Tian, Y. and Zhu, W. 2012. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro. Exp. Cell Res. 318, 944-954. https://doi.org/10.1016/j.yexcr.2012.02.010
- Yin, J., Ding, J., Huang, L., Tian, X., Shi, X., Zhi, L., Song, J., Zhang, Y., Gao, X., Yao, Z., Jing, X. and Yang, J. 2013. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression. Anat. Rec. (Hoboken) 296, 1568-1575. https://doi.org/10.1002/ar.22737
- Zeng, L., He, X., Wang, Y., Tang, Y., Zheng, C., Cai, H., Liu, J., Wang, Y., Fu, Y. and Yang, G. Y. 2014. MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain. Gene Ther. 21, 37-43. https://doi.org/10.1038/gt.2013.55
- Zhang, Z., Sun, H., Dai, H., Walsh, R. M., Imakura, M., Schelter, J., Burchard, J., Dai, X., Chang, A. N., Diaz, R. L., Marszalek, J. R., Bartz, S. R., Carleton, M., Cleary, M. A., Linsley, P. S. and Grandori, C. 2009. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8, 2756-2768. https://doi.org/10.4161/cc.8.17.9387
- Zhao, L., Jiang, S. and Hantash, B. M. 2010. Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue. Eng. Part. A. 16, 725-733. https://doi.org/10.1089/ten.tea.2009.0495